To hear about similar clinical trials, please enter your email below
Trial Title:
Prospective Observational Study of a Precision Medicine Approach in Patients With Advanced Cancer
NCT ID:
NCT05926284
Condition:
Cancer
Study type:
Observational [Patient Registry]
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Summary:
Prospective observational study of a precision medicine approach in patients with
advanced cancer. In this registrational study, patients with advanced cancer undergoing
extensive molecular sequencing within the precision oncology program of Charité
University Medicine, Berlin will be registered and followed to assess the efficacy of the
program and assess the clinical relevance and frequency of molecular alterations,
individualized therapies and novel molecular analysis tools.
Criteria for eligibility:
Study pop:
Patients with advanced cancer presenting to the precision oncology program at Charité for
molecular analyses to identify personalized treatment options.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- advanced cancer
- ability to give written informed consent
- performance status allows initiation of a potential targeted treatment after
molecular analysis
- molecular analysis has been done or planned
Exclusion Criteria:
- unable to give written informed consent
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Locations:
Facility:
Name:
Charité Comprehensive Cancer Center
Address:
City:
Berlin
Zip:
10117
Country:
Germany
Status:
Recruiting
Contact:
Last name:
Damian T Rieke, MD
Phone:
+49 (0)30 450 564 222
Email:
cccc@charite.de
Start date:
March 1, 2016
Completion date:
March 1, 2031
Lead sponsor:
Agency:
Charite University, Berlin, Germany
Agency class:
Other
Source:
Charite University, Berlin, Germany
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05926284
